Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

Bloomberg

BusinessBloomberg·Jul 29, 2026·1 min read

Goldman-Backed Biotech Attovia Seeks $212.5 Million in US IPO

Attovia Therapeutics Inc., an early-stage drug developer focused on immune-mediated diseases with high unmet need, is seeking to raise as much as $212.5 million in a US initial public offering.

View original source — Bloomberg ↗

ShareShare on X Share on Facebook

Related stories

Why the USO oil ETF is a better buy than crude futures as the Iran war rages

BusinessJul 29, 2026 · 1 min

Why the USO oil ETF is a better buy than crude futures as the Iran war rages

Warsh vows not to 'waver' on inflation as divided Fed leaves rates unchanged

BusinessJul 29, 2026 · 1 min

Warsh vows not to 'waver' on inflation as divided Fed leaves rates unchanged

Equinix shares fall on soft third-quarter forecast

BusinessJul 29, 2026 · 1 min

Equinix shares fall on soft third-quarter forecast

The World Bank president is in Mexico with plans to boost the economy

Mexico News Daily

BusinessJul 29, 2026 · 1 min

The World Bank president is in Mexico with plans to boost the economy

Mexico News Daily